---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-028331"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2022-10-13T23:59:59+00:00"
generated_at: "2026-06-23T03:53:26.066816+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Anebulo Pharmaceuticals adopts amended bylaws to comply with universal proxy rules

## Summary
- Board of Directors adopted Amended and Restated Bylaws on October 11, 2022.
- Updated advance notice procedures for stockholder proposals to require additional information.
- Added classified Board provision consistent with existing certificate of incorporation.
- Implemented supermajority stockholder vote requirement for any future bylaw amendments.
- Removed President's authority to call special meetings of stockholders or the Board.

## SEC filing metadata
- accession: 0001493152-22-028331
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2022-10-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315222028331/0001493152-22-028331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315222028331/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-028331
- JSON: https://secwatch.observer/filing/0001493152-22-028331.json
- Plain text: https://secwatch.observer/filing/0001493152-22-028331.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.